| Ticker | Company | Mkt Cap▼ | Price | Chg% | Volume |
|---|---|---|---|---|---|
| Medtronic plc | $94.8b | $81.39 | -0.7% | 15.3M | |
| Edwards Lifesciences Corp | $49.8b | $85.96 | -1.7% | 5.8M | |
| Alcon Inc. Ordinary Shares | $32.3b | $66.81 | +0.3% | 1.4M | |
| Biogen Inc. Common Stock | $28.9b | $195.33 | -0.6% | 880.4K | |
| Zimmer Biomet Holdings, Inc. | $15.9b | $87.33 | +0.7% | 2.0M | |
| Glaukos Corporation | $6.1b | $125.00 | +2.7% | 1.4M | |
| Bausch + Lomb Corporation | $5.6b | $15.46 | +0.7% | 585.3K | |
| Denali Therapeutics Inc. Common Stock | $3.3b | $19.50 | -3.1% | 2.2M | |
| Anteris Technologies Global Corp. Common Stock | $0.8b | $9.63 | -0.2% | 1.3M | |
| BioAge Labs, Inc. Common Stock | $0.8b | $15.67 | -7.9% | 376.0K | |
| Bioventus Inc. Class A Common Stock | $0.6b | $9.03 | +3.8% | 698.4K | |
| AC Immune SA | $270.7m | $2.24 | -6.7% | 327.6K | |
| LENZ Therapeutics, Inc. Common Stock | $243.9m | $7.01 | -2.6% | 494.9K | |
| Alector, Inc. Common Stock | $239.8m | $1.64 | -9.7% | 364.4K | |
| Acumen Pharmaceuticals, Inc. Common Stock | $187.8m | $2.14 | -6.5% | 319.6K | |
| Alpha Cognition Inc. Common Stock | $134.8m | $5.81 | -1.7% | 45.5K | |
| Outlook Therapeutics, Inc. Common Stock | $108.5m | $0.78 | -2.4% | 12.1M | |
| Cognition Therapeutics, Inc. Common Stock | $105.6m | $1.28 | -5.5% | 1.1M | |
| Telomir Pharmaceuticals, Inc. Common Stock | $89.4m | $1.22 | -3.9% | 73.4K | |
| Annovis Bio, Inc. | $81.7m | $1.89 | -5.0% | 1.4M | |
| Envoy Medical, Inc. Class A Common Stock | $54.2m | $0.65 | -7.3% | 97.0K | |
| Greenland Mines Ltd. Common Stock | $43.2m | $0.30 | -10.1% | 3.7M | |
| NeuroSense Therapeutics Ltd. Ordinary Shares | $29.7m | $0.75 | -3.9% | 102.1K | |
| CervoMed Inc. Common Stock | $28.8m | $2.98 | -4.5% | 62.2K | |
| Longeveron Inc. Common Stock | $24.4m | $0.73 | -8.4% | 306.4K | |
| OSR Holdings, Inc. Common Stock | $15.3m | $0.39 | -6.6% | 986.7K | |
| HCW Biologics Inc. Common Stock | $14.2m | $1.63 | -0.3% | 793.1K | |
| 20/20 Biolabs, Inc. Common Stock | $9.2m | $0.82 | -5.7% | 175.9K | |
| FibroBiologics, Inc. Common Stock | $6.0m | $0.99 | -7.5% | 75.0K | |
| Alzamend Neuro, Inc. Common Stock | $4.5m | $1.12 | -1.8% | 17.3K |